Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
2011

PIK3CA Mutations in Gallbladder Carcinoma

Sample size: 77 publication Evidence: moderate

Author Information

Author(s): Deshpande Vikram, Nduaguba Afamefuna, Zimmerman Stephanie M, Kehoe Sarah M, MacConaill Laura E, Lauwers Gregory Y, Ferrone Cristina, Bardeesy Nabeel, Zhu Andrew X, Hezel Aram F

Primary Institution: Massachusetts General Hospital, Harvard Medical School

Hypothesis

To characterize mutations in established oncogenes and tumor suppressor genes in biliary tract cancers.

Conclusion

Activating mutations in PIK3CA are specifically found in gallbladder carcinoma, which has implications for diagnosis and targeted therapies.

Supporting Evidence

  • Activating mutations in PIK3CA were identified in 4 out of 32 gallbladder carcinoma samples.
  • KRAS mutations were found in intra-hepatic cholangiocarcinomas but not in gallbladder carcinomas.
  • The study used a high-throughput mass-spectrometric platform for mutation profiling.

Takeaway

This study found that a specific mutation in a gene called PIK3CA is common in gallbladder cancer, which could help doctors treat this type of cancer better.

Methodology

Mass spectrometric genotyping was used to analyze mutations in 77 formalin-fixed paraffin-embedded biliary tract cancer samples.

Limitations

The study may have missed some mutations due to the quality of DNA extracted from samples.

Participant Demographics

The cohort included 33 gallbladder carcinoma samples with a mean age of 66 years, consisting of 25 females and 8 males.

Statistical Information

P-Value

0.013

Statistical Significance

p = 0.013

Digital Object Identifier (DOI)

10.1186/1471-2407-11-60

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication